Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

LGMD2E patients risk developing dilated cardiomyopathy.

Neuromuscular disorders : NMD - 1 May 2003

Fanin M, Melacini P, Boito C, Pegoraro E, Angelini C

Abstract excerpt

Sarcoglycan gene mutations cause various limb-girdle muscular dystrophies. The sarcoglycans are expressed both in skeletal and cardiac muscle but, surprisingly, so far only a few sarcoglycanopathy patients have had documented cardiomyopathy. We studied six patients with beta-sarcoglycanopathy. Immunohistochemical and immunoblot analysis performed on skeletal muscle biopsies from five patients, showed the loss of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy
Share to Cardiomyopathy, Dilated
Share to Cytoskeletal Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dystroglycans

Share to Membrane Glycoproteins

Share to Muscle, Skeletal

Share to Muscular Dystrophies

Share to Severity of Illness Index

Source

Identifiers

PMID: 12868499
DOI: 10.1016/s0960-8966(02)00280-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

LGMD2E patients risk developing dilated cardiomyopathy.PMID 12868499Read ↗

Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by beta sarcoglycan mutations.Semantic proximity Read ↗

Heart involvement in muscular dystrophies due to sarcoglycan gene mutations.Semantic proximity Read ↗

Cardiomyopathy in muscular dystrophies.Semantic proximity Read ↗

Cardiomyopathy in muscular dystrophiesSemantic proximity Read ↗

[Sarcoglycanopathies: state of the art and therapeutic perspectives].Semantic proximity Read ↗

Clinical and genetic spectrum in limb-girdle muscular dystrophy type 2E.Semantic proximity Read ↗

Sarcoglycanopathies: a clinico-pathological study.Semantic proximity Read ↗

Dystrophin-Deficient Cardiomyopathy.Semantic proximity Read ↗

Evaluation of cardiac and respiratory involvement in sarcoglycanopathies.Semantic proximity Read ↗

[Sarcoglycanopathies].Semantic proximity Read ↗

From dystrophinopathy to sarcoglycanopathy: evolution of a concept of muscular dystrophy.Semantic proximity Read ↗

Invited commentary. Sarcoglycanopathies: a clinico-pathological study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.